» Articles » PMID: 21698478

Neurocysticercosis: Local and Systemic Immune-inflammatory Features Related to Severity

Overview
Date 2011 Jun 24
PMID 21698478
Citations 11
Authors
Affiliations
Soon will be listed here.
Abstract

Neurocysticercosis (NC) is caused by the establishment of Taenia solium cysticerci in the central nervous system. Previous studies have established that neuroinflammation plays a key role in the severity of the disease. However, the relationship between peripheral and local immune response remains inconclusive. This work studies the peripheral and local immune-inflammatory features and their relationships, toward the identification of potential peripheral immunologic features related to severity. A panel of cytokines was measured in paired cerebrospinal fluid (CSF) and in the supernatant of antigen-specific stimulated peripheral blood mononuclear cells samples (SN) in a total of 31 untreated inflammatory and non-inflammatory NC patients. Increased clinical and radiologic severity was associated with an increased cerebrospinal fluid cell count. A peripheral proliferative depression that negatively correlates with CSF cellularity and TNFα and that positively correlates with SN IL5 was observed in severe NC patients. These results provide evidences to support the systemic proliferative response as a biomarker to monitor the level of neuroinflammation, of possible value in the patients' follow-up during treatment.

Citing Articles

Evaluating the modulation of peripheral immune profile in people living with HIV and (Neuro)cysticercosis.

Lema Y, Prodjinotho U, Makasi C, Nanyaro M, Kilale A, Mfinanga S PLoS Negl Trop Dis. 2024; 18(8):e0012345.

PMID: 39093864 PMC: 11324146. DOI: 10.1371/journal.pntd.0012345.


Efficiency of Cysticidal Therapy Impacted by the Host's Immune Response in Neurocysticercosis Patients.

Mehta Y, Kaur D, Kaur U, Shree R, Singh P, Modi M Mol Neurobiol. 2024; 62(2):2203-2211.

PMID: 39090352 DOI: 10.1007/s12035-024-04377-0.


The role of helminths in the development of non-communicable diseases.

Wu Y, Duffey M, Alex S, Suarez-Reyes C, Clark E, Weatherhead J Front Immunol. 2022; 13:941977.

PMID: 36119098 PMC: 9473640. DOI: 10.3389/fimmu.2022.941977.


The Local Inflammatory Profile and Predictors of Treatment Success in Subarachnoid Neurocysticercosis.

Harrison S, Thumm L, Nash T, Nutman T, OConnell E Clin Infect Dis. 2020; 72(9):e326-e333.

PMID: 33269789 PMC: 8096242. DOI: 10.1093/cid/ciaa1128.


Host immune responses during Taenia solium Neurocysticercosis infection and treatment.

Prodjinotho U, Lema J, Lacorcia M, Schmidt V, Vejzagic N, Sikasunge C PLoS Negl Trop Dis. 2020; 14(4):e0008005.

PMID: 32298263 PMC: 7162612. DOI: 10.1371/journal.pntd.0008005.


References
1.
Wilson E, Wille-Reece U, Dzierszinski F, Hunter C . A critical role for IL-10 in limiting inflammation during toxoplasmic encephalitis. J Neuroimmunol. 2005; 165(1-2):63-74. DOI: 10.1016/j.jneuroim.2005.04.018. View

2.
Chavarria A, Fleury A, Garcia E, Marquez C, Fragoso G, Sciutto E . Relationship between the clinical heterogeneity of neurocysticercosis and the immune-inflammatory profiles. Clin Immunol. 2005; 116(3):271-8. DOI: 10.1016/j.clim.2005.04.008. View

3.
Rolfs A, Muhlschlegel F, Martins A, Bedaque E, Tamburus W, Pedretti L . Clinical and immunologic follow-up study of patients with neurocysticercosis after treatment with praziquantel. Neurology. 1995; 45(3 Pt 1):532-8. DOI: 10.1212/wnl.45.3.532. View

4.
McFarlane E, Perez C, Charmoy M, Allenbach C, Christine Carter K, Alexander J . Neutrophils contribute to development of a protective immune response during onset of infection with Leishmania donovani. Infect Immun. 2007; 76(2):532-41. PMC: 2223441. DOI: 10.1128/IAI.01388-07. View

5.
Bueno E, Vaz A, Machado L, Livramento J, Avila S, Ferreira A . Antigen-specific suppression of cultured lymphocytes from patients with neurocysticercosis. Clin Exp Immunol. 2001; 126(2):304-10. PMC: 1906206. DOI: 10.1046/j.1365-2249.2001.01579.x. View